In a significant development for the treatment of neurodegenerative disorders, Boston-based biotechnology firm Cerevance announced on Wednesday...
Treatment Innovations
As the global pharmaceutical landscape undergoes a period of rapid transformation—fueled by artificial intelligence, the maturation of...
By Gwendolyn Wu Published October 6, 2026 In a move that sends a powerful signal of confidence...
The landscape of personal health technology has shifted significantly with the recent regulatory approval of the Happy...
The landscape of drug discovery is undergoing a profound paradigm shift. For decades, the pathology workflow was...
In a significant milestone for neural engineering and restorative ophthalmology, Science Corporation has unveiled compelling long-term data...
By Gwendolyn Wu Published October 6, 2026 In a move that signals a renewed sense of urgency...
In the landscape of modern drug discovery, the traditional animal study has long been regarded as a...
In a significant milestone for neural engineering and ophthalmology, Science Corporation has unveiled compelling long-term data from...
In a landmark development for the European life sciences sector, Netherlands-based venture capital firm Forbion has successfully...
